Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

Clinical trial NCT05586958 · COMPLETED

Trial details

NCT number: NCT05586958
Sponsor: LG Chem
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gout Hyperuricemia Gout Flare Tophi

Start date: 2022-10-25
Primary completion: 2024-11-04
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.